Working together to provide support to countries in light of Global Fund new funding model

Working together to provide support to countries in light of Global Fund new

funding model

Nigeria Country

Experience

Dr A. O. Awe, NPO TUB/WHO

Outline

1. Country name, submission date

2. Partners involved Lessons learned:

3. What worked well

4. What didn't work well

Nigeria Current TB grant

• Current TB GF Grant: Phase 2 of Rd 9

• Phase 2 period: Jan 2013 –June 2015

• 2 PRs: ARFH IHVN (MDR component)

Country NFM Process• The Nigeria CCM is coordinating the development

and submission of concept notes using the New Funding Model (NFM) to access funding for HIV/AIDS, Tuberculosis, Malaria and Health System Strengthening (HSS).

• The HMH chairs the CCM; WHO WR act as RMC chair

• Key feature of NFM is the “country dialogue”.

• The CCM also coordinated the Roadmap for the Joint TB/HIV Concept Note writing.

Road map for NFM• CCM constituted a Multi-stakeholder NFM Core

Team with clear ToR to drive the preparation and application processes

• Included governments, donors, technical partners, civil society, and key affected and most-at-risk populations.

• The country dialogue led to identification of national strategies, resource available, TA needs and country prioritized activities for TB/HIV .

• Joint TA plan and ToRs developed; recruitment of TAs still on-going (19 thematic areas identified for TA support for the TB/HIV concept note)

Nigeria NFM TB/HIV timelines Key dates: in discussion with GF secretariat;

•CCM Final TB/HIV CN submission: 15 August 2014

•Technical Review Panel (TRP) review: 15 Sept 2014

•1st Grant Approvals Committee (GAC) meeting: Sept 2014

•Grant making: October 2014- January 2015

•2nd GAC meeting: February 2015

•Board meeting/approval: March 2015

•Sign additional grant funding: by April 2015

•Availability of new grant funding: 1 July 20156

Progress with Ingredients for Joint Concept NoteComponent COMPLETION?? Key TA Provision

by ??TB HIV

1 National Program review YES YES WHO, KNCV, USAID, CDC, etc

2 National Strategic Plan Almost YES D arcy/ Daniella3 Epi Analysis YES YES Babis(WHO HQ)4 Programmatic/Financial

Gap AnalysisYes Ongoing

5 Target setting Yes On going

D arcy/ Daniella, UNAIDS

6 HSS assessment /analysis Ongoing “” WHO7 Identify joiTB/HIV priorit Ongoing On No Ext consultant

8 Consultative/technical meetings b/w GF and PEPFAR on Prioritization of support; HELD

GF, USAID, GON

TA SUPPORT REQUEST AREA ACCORDING TO NFM MODULES

TA SUPPORT REQUEST AREA ACCORDING TO NFM MODULES

EXTERNAL TAs INVOLVED

1 TB Care and Prevention USAID, KNCV, WHO

2 MDR TB KNCV, WHO, USAID

3 PMTCT UNICEF

4 ART WHO

5 HIV Prevention and Most Risked person

UNAIDS, UNDP, UNODC

6 Health System Strengthening WHO, UNDP

7 NFM Concept note drafting (narrative sections)

WHO

8 Concept note development leadership

UNAIDS (HIV); USAID/KNCV (TB)HSS (WHO)

9 Cross cutting support UNAIDS, UNDP, WHOMarch 2012Off-Cycle Phase 2 Panel 8

What worked well• Central coordination by CCM

• Harmonisation of roadmap; TA needs.

• Readiness of stakeholders and Partners to dialogue to identify way forward.

• National TB and HIV Programme and stakeholders working closely together on the processes of the joint concept note writing

• Coordination of TA from TBTEAM, WHO, KNCV and UNAIDs

What did not work well/ Challenges

• Not all TA pledged / consultants were available at time specified, especially on HIV side

• Still looking for external TB/HIV consultant

• Shifting dates on roadmap

THANK YOU!